Opportunity Information: Apply for HRSA 13 154
Apply for HRSA 13 154
- The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Culturally Appropriate Interventions of Outreach, Access and Retention among Latino/a Populations Demonstration Sites" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.928 Special Projects of National Significance.
- This funding opportunity was created on Feb 22, 2013 and posted on Jan 23, 2013.
- Applicants must submit their applications by Mar 18, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 8 candidate(s).
- Eligible applicants include: City or township governments State governments Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts Special district governments County governments Public and State controlled institutions of higher education.
- Eligible applicants include public and nonprofit entities funded under Ryan White HIV Program Parts A, B, C and D. These include, but are not limited to state and local governments academic institutions local health departments hospitals and outpatient
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Health Resources and Services Administration (HRSA) offered this Special Projects of National Significance (SPNS) grant opportunity to fund a multi-site set of demonstration projects aimed at improving HIV-related health outcomes for Latino/a people in the United States. The core purpose was to support organizations that would design, implement, and evaluate culturally appropriate service delivery models that strengthen outreach, improve access to care, and increase retention in high-quality HIV primary care. Rather than paying for clinical treatment itself, the program was designed to fund practical, community- and clinic-linked strategies that help Latino/a individuals get diagnosed, successfully enter care quickly, and stay engaged over time.
The initiative specifically targeted Latino/a people who are at elevated risk for HIV infection, as well as those already living with HIV who face gaps along the HIV care continuum. Priority populations included individuals who are HIV-positive but do not know their status, people who know they are HIV-positive but have never engaged in care, people who refused referral after diagnosis, and those who previously entered care but later dropped out. Applicants were expected to propose innovative ways to find and reach these groups and then reduce the barriers that keep them from connecting to and remaining in care.
A central feature of the announcement was its emphasis on culturally appropriate and transnationally informed approaches. Projects were expected to tailor interventions to specific Latino/a subpopulations in the US in ways that reflect country-of-origin differences and the realities of migration, language, family dynamics, and community norms. Interventions also needed to address sociocultural and structural barriers, with special attention to stigma, that can prevent timely testing, linkage, and long-term retention in HIV care. The opportunity highlighted a broad range of Latino/a subpopulations that could be addressed, including heterosexual men and women, gay and bisexual men, bisexual women, transgender women, and people who inject drugs, among others.
Eligible applicants were public and nonprofit entities funded under the Ryan White HIV/AIDS Program Parts A, B, C, and D, which could include state and local governments, academic institutions, local health departments, hospitals, and outpatient providers. Applicants had to demonstrate clinical capacity, meaning they needed to be able to implement and sustain their proposed models in real service settings and ensure that participants could be connected to appropriate HIV primary care. The program also encouraged collaboration, including consortia of multiple outpatient clinics serving the same target population, particularly when working in geographic areas with concentrated need.
Geographically, awards were limited to organizations located in areas with a high concentration of Latino/a residents and a high incidence and/or prevalence of HIV/AIDS, especially urban areas. This requirement reflected the program's intent to invest in settings where successful models could have a meaningful and measurable impact and where lessons learned could be valuable for replication elsewhere.
Funding was structured as up to eight awards, with a ceiling of $300,000 per year for a five-year project period (covering federal fiscal years 2013 through 2017). There was no cost-sharing or matching requirement. Importantly, funds could not be used for direct HIV care services or to duplicate services already supported through other funding streams. Instead, the grant dollars were intended for the added-value activities that move people into care and keep them there, while clinical care itself would continue to be funded through other mechanisms such as Ryan White Parts A through D.
Evaluation was a major requirement. Each funded demonstration site had to participate in a comprehensive multi-site evaluation across the five-year period, led by an Evaluation and Technical Assistance Center (ETAC). The purpose of this evaluation structure was to identify, document, and compare promising or effective models so they could be disseminated nationally and replicated by other organizations. HRSA made ETAC funding available under a separate announcement (HRSA-13-151), and applicants could not apply for both the demonstration site funding (HRSA-13-154) and the ETAC award.
Key administrative details included Funding Opportunity Number HRSA-13-154, CFDA 93.928 (Special Projects of National Significance), a discretionary grant instrument, and an original and final closing date of March 18, 2013 (later archived May 15, 2013). For access issues, applicants were directed to the HRSA Call Center (877-464-4772) or CallCenter@HRSA.GOV.
Frequently Asked Questions (FAQs)
1) What is this HRSA SPNS grant opportunity intended to do?
This HRSA Special Projects of National Significance (SPNS) opportunity funds a multi-site set of demonstration projects designed to improve HIV-related health outcomes for Latino/a people in the United States. The focus is on practical, culturally appropriate service delivery models that strengthen outreach, improve access to care, and increase retention in high-quality HIV primary care.
2) Is this grant meant to pay for HIV medical treatment or clinical care?
No. The program is not intended to fund direct HIV care services or clinical treatment itself. Instead, it supports community- and clinic-linked strategies that help people get diagnosed, enter care quickly, and stay engaged over time, while HIV primary care continues to be supported through other mechanisms (such as Ryan White Parts A through D).
3) Who is the primary population this funding is meant to serve?
The initiative targets Latino/a people in the United States who are at elevated risk for HIV infection, as well as Latino/a people living with HIV who experience gaps along the HIV care continuum.
4) Which priority groups along the HIV care continuum are specifically highlighted?
The opportunity emphasizes reaching and supporting Latino/a individuals who:
- Are HIV-positive but do not know their status
- Know they are HIV-positive but have never engaged in care
- Refused referral after diagnosis
- Previously entered care but later dropped out
5) What types of strategies or interventions are applicants expected to propose?
Applicants are expected to propose innovative, culturally appropriate approaches to identify and reach priority populations, reduce barriers to linkage and retention, improve access to care, and increase long-term engagement in HIV primary care. The emphasis is on service delivery models that work in real community and clinical settings.
6) What does "culturally appropriate and transnationally informed" mean in this announcement?
Projects are expected to tailor interventions to specific Latino/a subpopulations in ways that reflect country-of-origin differences and the realities of migration, language, family dynamics, and community norms. Interventions also need to address sociocultural and structural barriers, with special attention to stigma, that can prevent timely testing, linkage, and retention in care.
7) Which Latino/a subpopulations may be addressed under this initiative?
The opportunity highlights a broad range of Latino/a subpopulations that could be addressed, including heterosexual men and women, gay and bisexual men, bisexual women, transgender women, and people who inject drugs, among others.
8) Who is eligible to apply for this funding?
Eligible applicants are public and nonprofit entities funded under the Ryan White HIV/AIDS Program Parts A, B, C, and D. Examples include state and local governments, academic institutions, local health departments, hospitals, and outpatient providers.
9) Does an applicant need to show clinical capacity?
Yes. Applicants must demonstrate clinical capacity, meaning they must be able to implement and sustain the proposed model in real service settings and ensure that participants can be connected to appropriate HIV primary care.
10) Are partnerships or consortia encouraged?
Yes. Collaboration is encouraged, including consortia of multiple outpatient clinics serving the same target population, particularly when working in geographic areas with concentrated need.
11) Are there geographic limitations for where awards can go?
Yes. Awards are limited to organizations located in areas with a high concentration of Latino/a residents and a high incidence and/or prevalence of HIV/AIDS, especially urban areas.
12) How many awards are expected, and what is the funding level?
Funding is structured as up to eight awards. The ceiling is $300,000 per year per award for a five-year project period.
13) What is the project period covered by this opportunity?
The project period is five years, covering federal fiscal years 2013 through 2017.
14) Is cost sharing or matching required?
No. There is no cost-sharing or matching requirement stated for this opportunity.
15) What costs or activities are not allowed with these grant funds?
Funds cannot be used for direct HIV care services and cannot be used to duplicate services already supported through other funding streams. The grant is intended for added-value activities that improve diagnosis, linkage to care, and retention.
16) What is the role of evaluation in this program?
Evaluation is a major requirement. Each funded demonstration site must participate in a comprehensive multi-site evaluation across the five-year period, led by an Evaluation and Technical Assistance Center (ETAC). The goal is to identify, document, and compare promising or effective models for national dissemination and replication.
17) What is the ETAC, and how is it funded?
The Evaluation and Technical Assistance Center (ETAC) leads the multi-site evaluation. ETAC funding is available under a separate announcement (HRSA-13-151).
18) Can an organization apply to be both a demonstration site and the ETAC?
No. Applicants cannot apply for both the demonstration site funding (HRSA-13-154) and the ETAC award (HRSA-13-151).
19) What is the Funding Opportunity Number and CFDA number for this grant?
The Funding Opportunity Number is HRSA-13-154. The CFDA number is 93.928 (Special Projects of National Significance).
20) What type of grant mechanism is used for this opportunity?
This is a discretionary grant instrument.
21) What were the application closing dates for this opportunity?
The original and final closing date listed was March 18, 2013. The opportunity was later archived on May 15, 2013.
22) Who should applicants contact if they have access issues?
For access issues, applicants were directed to the HRSA Call Center at 877-464-4772 or CallCenter@HRSA.GOV.
Browse more opportunities from the same category: Health
Next opportunity: Comprehensive Housing Counseling Program
Previous opportunity: Self Help Homeownership Opportunity Program (SHOP)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 13 154
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 13 154) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening National Health Laboratory Services in Uganda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1333 Funding Number: CDC RFA GH13 1333 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| FY 2013 Targeted Capacity Expansion Peer to Peer Apply for TI 13 001 Funding Number: TI 13 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $250,000 |
| Technical Assistance Services to Countries Supported by the Presidents Emergency Plan for HIV/AIDS Relief (PEPFAR) and the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Apply for CDC RFA GH13 1368 Funding Number: CDC RFA GH13 1368 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $15,000,000 |
| Modification no. 2 Apply for APS 442 13 000001 MOD2 Funding Number: APS 442 13 000001 MOD2 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $100,000 |
| Human Heredity and Health in Africa (H3Africa) Ethical, Legal, and Societal Issues (ELSI) Research Program (U01) Apply for RFA RM 13 005 Funding Number: RFA RM 13 005 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (STTR)(R41/R42) Apply for PA 13 093 Funding Number: PA 13 093 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (SBIR)(R43/R44) Apply for PA 13 092 Funding Number: PA 13 092 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical and Public Health Curriculum Development, Training and Information Systems Support for the Haiti Health Care System under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1331 Funding Number: CDC RFA GH13 1331 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Accelerating Delivery of Comprehensive HIV/AIDS in High Prevalence, Underserved Districts In The Republic Of Uganda Under The Presidents Emergency Plan For AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1332 Funding Number: CDC RFA GH13 1332 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,203,759 |
| Capacity Strengthening to Support Provision of High Quality and Evidence based HIV Prevention, Care and Treatment Services to Staff and Family Members of the Kenya Prisons Services Staff, Family Members, and Prisoners in Kenya and Program Transition Apply for CDC RFA GH13 1308 Funding Number: CDC RFA GH13 1308 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Increasing HIV/AIDS Program Capacity through Human Resources Capacity Building to Support the Transition of the Kenya HIV Program to Local Organizations under the Presidents Emergency Plan for AIDS Relief (PEPFAR). Apply for CDC RFA GH13 1309 Funding Number: CDC RFA GH13 1309 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Technical Assistance for the Transition of Comprehensive HIV/AIDS Programs and Medical Education to Ethiopia under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1310 Funding Number: CDC RFA GH13 1310 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $8,000,000 |
| Improving Public Health Practices and Service Delivery in the Federal Democratic Republic of Ethiopia with a Focus on HIV, Sexually Transmitted Infections, and Tuberculosis under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1314 Funding Number: CDC RFA GH13 1314 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Strengthening Strategic Information Activities in the Kingdom of Lesotho under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1315 Funding Number: CDC RFA GH13 1315 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,200,000 |
| Improving Implementation of Programs for Care Apply for CDC RFA GH13 1317 Funding Number: CDC RFA GH13 1317 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Technical assistance to accelerate the elimination of mother to child transmission (EMTCT) of HIV and improve HIV free child survival in the Republic of Zambia under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1350 Funding Number: CDC RFA GH13 1350 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,000,000 |
| Strengthening Local Ownership for the Sustainable Provision of Comprehensive HIV/AIDS Services by the Health Bureaus of Amhara and Tigray Regional States of the Federal Democratic Republic of Ethiopia under the Presidents Emergency Plan for AIDS Reli Apply for CDC RFA GH13 1311 Funding Number: CDC RFA GH13 1311 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Strengthening Capacity for Laboratory Systems, Strategic Information, and Technical Leadership in Public Health for the National HIV/AIDS Response in the Federal Democratic Republic of Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEP Apply for CDC RFA GH13 1313 Funding Number: CDC RFA GH13 1313 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Implementation of Integrated HIV/AIDS Treatment, Care and Prevention Programs in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief Apply for CDC RGA GH13 1316 Funding Number: CDC RGA GH13 1316 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Clinical Sites for an Undiagnosed Diseases Network (UDN) (U01) Apply for RFA RM 13 004 Funding Number: RFA RM 13 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 13 154", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.